BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1134680)

  • 21. [Semiquantitative immunological determinations of chorionic gonadotropins with the gravimun test in normal pregnancy and in threatened abortion].
    Nieder J; Kapitz W
    Zentralbl Gynakol; 1970 Jun; 92(23):721-7. PubMed ID: 5513302
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical contribution on the use of delayed-action isoxsuprine in threatened abortion].
    Sola O; Colonna-Romano L
    Arch Ostet Ginecol; 1974; 79(5-6):326-35. PubMed ID: 4471560
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effects of isoxsuprine hydrochloride in threatened abortion].
    Cazzola D
    Quad Clin Ostet Ginecol; 1967 Jun; 22(6):382-96. PubMed ID: 5628977
    [No Abstract]   [Full Text] [Related]  

  • 24. [On the problems of progesterone treatment of threatened abortion].
    Steinhoff R
    Dtsch Gesundheitsw; 1967 Aug; 22(32):1502-6. PubMed ID: 5590026
    [No Abstract]   [Full Text] [Related]  

  • 25. [Spasmolytic therapy with Sistalgin in obstetrics and gynecology].
    Lucchese A
    Minerva Ginecol; 1975 Jul; 27(7):559-69. PubMed ID: 1239699
    [No Abstract]   [Full Text] [Related]  

  • 26. Progesterone - induced blocking factor (PIBF) and Th(1)/Th(2) cytokine in women with threatened spontaneous abortion.
    Hudić I; Fatusić Z
    J Perinat Med; 2009; 37(4):338-42. PubMed ID: 19290853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The pharmacodynamic action of caffeine. Deductions in clinical obstetrics].
    Crainicianu A
    Minerva Ginecol; 1971 Dec; 23(23):984-9. PubMed ID: 5167813
    [No Abstract]   [Full Text] [Related]  

  • 28. [On the prevention of spontaneous abortions and therapeutic prevention of threatened abortion].
    Vago O
    Z Arztl Fortbild (Jena); 1968 Jun; 62(11):573-8. PubMed ID: 4878194
    [No Abstract]   [Full Text] [Related]  

  • 29. [Vaginal adenocarcinoma as a late result of treatment of threatened abortion with diethylstilbestrol].
    Presl J
    Cesk Gynekol; 1973 Jul; 38(6):473-4. PubMed ID: 4731614
    [No Abstract]   [Full Text] [Related]  

  • 30. [On the use of a spasmolytic, analgesic and sedative combination in the treatment of obstetrico-gynecologic diseases].
    Avezzù G
    Ann Ostet Ginecol Med Perinat; 1967 Jul; 89(7):442-62. PubMed ID: 5628145
    [No Abstract]   [Full Text] [Related]  

  • 31. [Toxoplasmosis and threatened abortion].
    Romero Cabello R; Buitrón García R; Amancio Chasin O; Tay Zavala J; Sánchez Vega JT
    Ginecol Obstet Mex; 1998 Dec; 66():495-8. PubMed ID: 9951178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [No. 244. Elementary prescriptions for therapy of threatened abortion].
    Calzolari E
    Clin Ter; 1972 Jun; 61(6):577-82. PubMed ID: 4677564
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical experience with Diazepam in threatened abortion].
    Kawakami H; Yoshida S; Yoshida T; Makita M; Watanabe M
    Sanfujinka No Jissai; 1966 Mar; 15(3):270-7. PubMed ID: 6013899
    [No Abstract]   [Full Text] [Related]  

  • 34. The impact of dydrogesterone supplementation on hormonal profile and progesterone-induced blocking factor concentrations in women with threatened abortion.
    Kalinka J; Szekeres-Bartho J
    Am J Reprod Immunol; 2005 Apr; 53(4):166-71. PubMed ID: 15760377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Results of hormonal treatment in threatened and habitual abortion].
    Tarlantas D; Moschovakis K
    Geburtshilfe Frauenheilkd; 1966 May; 26(5):563-4. PubMed ID: 5935246
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical use of Intacerin in threatened abortion].
    Watanabe K; Okano S; Iwai K; Suzumori K
    Sanfujinka No Jissai; 1968 Nov; 17(11):1018-22. PubMed ID: 5756208
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical use of a beta-mimetic drug in the control of uterine dynamics].
    Casati G; Scaglione V; Vandelli I
    Ann Ostet Ginecol Med Perinat; 1973; 94(9-10):587-94. PubMed ID: 4806144
    [No Abstract]   [Full Text] [Related]  

  • 38. [The use of isoxsuprine in the treatment of threatened abortion].
    Massobrio M; Sismondi P; Capra A; Campagnoli C
    Minerva Ginecol; 1969 Nov; 21(22):1570-6. PubMed ID: 5393543
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of threatened abortion with human chorionic gonadotropin.
    Suvonnakote T
    J Med Assoc Thai; 1986 Dec; 69(12):654-8. PubMed ID: 3572279
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hormone therapy of threatened abortion (results of clinical use of chlormadinone acetate)].
    Seiga K; Yamaji K
    Iryo; 1966 Mar; 20(3):208-16. PubMed ID: 4164690
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.